Completed
V160 2-Dose and 3-Dose Regimens in Healthy Cytomegalovirus (CMV) Seronegative Females (V160-002)
NCT03486834
- Conditions
- Cytomegalovirus (CMV) Infections, Infections
- Locations
-
- Alabama Clinical Therapeutics ( Site 0025) Birmingham, Alabama, United States
- Achieve Clinical Research, LLC ( Site 0055) Birmingham, Alabama, United States
- Synexus US Phoenix Southeast ( Site 0057) Chandler, Arizona, United States
- Inland Empire Liver Foundation ( Site 0026) Rialto, California, United States